Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fibrin Fibrinogen Degradation Products | 6 | 2018 | 9 | 1.290 |
Why?
|
| Emergency Service, Hospital | 9 | 2018 | 252 | 1.280 |
Why?
|
| Pulmonary Embolism | 6 | 2011 | 55 | 0.800 |
Why?
|
| Fibrinolytic Agents | 3 | 2018 | 57 | 0.630 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 32 | 0.550 |
Why?
|
| Colonoscopy | 3 | 2020 | 70 | 0.520 |
Why?
|
| Emergency Medicine | 4 | 2015 | 93 | 0.500 |
Why?
|
| Medical Overuse | 1 | 2015 | 7 | 0.480 |
Why?
|
| Health Policy | 1 | 2015 | 28 | 0.470 |
Why?
|
| African Americans | 1 | 2014 | 1 | 0.430 |
Why?
|
| Premenopause | 1 | 2014 | 11 | 0.430 |
Why?
|
| Postmenopause | 1 | 2014 | 57 | 0.430 |
Why?
|
| Duodenal Diseases | 1 | 2013 | 2 | 0.410 |
Why?
|
| Vascular Fistula | 1 | 2013 | 2 | 0.410 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 6 | 0.410 |
Why?
|
| Intestinal Fistula | 1 | 2013 | 4 | 0.400 |
Why?
|
| Abdominal Pain | 1 | 2013 | 6 | 0.400 |
Why?
|
| Exercise | 1 | 2014 | 392 | 0.330 |
Why?
|
| Enema | 1 | 2010 | 2 | 0.330 |
Why?
|
| Polyethylene Glycols | 1 | 2010 | 35 | 0.320 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 69 | 0.300 |
Why?
|
| Humans | 25 | 2020 | 22823 | 0.290 |
Why?
|
| Critical Pathways | 1 | 2007 | 19 | 0.270 |
Why?
|
| Ischemic Attack, Transient | 1 | 2007 | 16 | 0.260 |
Why?
|
| Enterobius | 1 | 2006 | 1 | 0.250 |
Why?
|
| Enterobiasis | 1 | 2006 | 1 | 0.250 |
Why?
|
| Cecum | 1 | 2006 | 11 | 0.250 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 75 | 0.240 |
Why?
|
| Adult | 8 | 2018 | 6896 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 235 | 0.200 |
Why?
|
| Middle Aged | 10 | 2017 | 7873 | 0.190 |
Why?
|
| Aged | 8 | 2014 | 7412 | 0.190 |
Why?
|
| Sensitivity and Specificity | 6 | 2009 | 439 | 0.190 |
Why?
|
| Male | 12 | 2020 | 12400 | 0.170 |
Why?
|
| Health Services Research | 3 | 2015 | 29 | 0.170 |
Why?
|
| Decision Support Techniques | 2 | 2018 | 37 | 0.160 |
Why?
|
| Endoscopy, Digestive System | 1 | 2020 | 7 | 0.160 |
Why?
|
| Gastroenterology | 1 | 2020 | 9 | 0.160 |
Why?
|
| Pilot Projects | 2 | 2014 | 370 | 0.160 |
Why?
|
| Age Factors | 3 | 2018 | 633 | 0.150 |
Why?
|
| Female | 11 | 2020 | 12904 | 0.150 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 53 | 0.140 |
Why?
|
| Telephone | 1 | 1997 | 23 | 0.140 |
Why?
|
| Risk Factors | 4 | 2018 | 1966 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 1997 | 17 | 0.140 |
Why?
|
| Aftercare | 1 | 1997 | 22 | 0.140 |
Why?
|
| Knowledge | 2 | 2007 | 12 | 0.140 |
Why?
|
| Diffusion of Innovation | 2 | 2007 | 19 | 0.140 |
Why?
|
| Feasibility Studies | 3 | 2020 | 210 | 0.130 |
Why?
|
| Defecation | 1 | 2017 | 5 | 0.130 |
Why?
|
| Starch | 1 | 2017 | 9 | 0.130 |
Why?
|
| Microspheres | 1 | 2017 | 24 | 0.130 |
Why?
|
| Dietary Fiber | 1 | 2017 | 25 | 0.130 |
Why?
|
| Prebiotics | 1 | 2017 | 18 | 0.130 |
Why?
|
| Time Factors | 2 | 2015 | 1258 | 0.120 |
Why?
|
| Clinical Decision-Making | 1 | 2015 | 42 | 0.120 |
Why?
|
| Environment | 1 | 2015 | 36 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 572 | 0.120 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 41 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 69 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2008 | 546 | 0.110 |
Why?
|
| Prospective Studies | 4 | 2020 | 1487 | 0.110 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 2 | 0.110 |
Why?
|
| E-Selectin | 1 | 2014 | 3 | 0.110 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2014 | 4 | 0.110 |
Why?
|
| Lipoproteins, LDL | 1 | 2014 | 8 | 0.110 |
Why?
|
| Cell-Derived Microparticles | 1 | 2014 | 5 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2015 | 110 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 34 | 0.110 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 52 | 0.110 |
Why?
|
| Triglycerides | 1 | 2014 | 54 | 0.110 |
Why?
|
| Physical Fitness | 1 | 2014 | 47 | 0.110 |
Why?
|
| Cholesterol | 1 | 2014 | 57 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2014 | 58 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2014 | 99 | 0.100 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2013 | 11 | 0.100 |
Why?
|
| Gastrointestinal Transit | 1 | 2012 | 12 | 0.100 |
Why?
|
| Capsule Endoscopy | 1 | 2012 | 5 | 0.100 |
Why?
|
| Intestine, Small | 1 | 2012 | 30 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2014 | 377 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 309 | 0.090 |
Why?
|
| Headache | 1 | 2012 | 36 | 0.090 |
Why?
|
| Medicare | 1 | 2012 | 106 | 0.090 |
Why?
|
| Colonic Diseases | 1 | 2010 | 7 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 151 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 312 | 0.080 |
Why?
|
| Antifibrinolytic Agents | 1 | 2009 | 16 | 0.070 |
Why?
|
| Resuscitation | 1 | 2008 | 10 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2020 | 102 | 0.070 |
Why?
|
| Cause of Death | 1 | 2008 | 54 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2008 | 33 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2008 | 129 | 0.070 |
Why?
|
| Sepsis | 1 | 2008 | 75 | 0.070 |
Why?
|
| Information Dissemination | 1 | 2007 | 11 | 0.070 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 39 | 0.070 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2007 | 7 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2010 | 1019 | 0.070 |
Why?
|
| Calcitonin | 1 | 2006 | 9 | 0.060 |
Why?
|
| Protein Precursors | 1 | 2006 | 17 | 0.060 |
Why?
|
| ROC Curve | 2 | 2008 | 121 | 0.060 |
Why?
|
| Recurrence | 1 | 2007 | 268 | 0.060 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2005 | 3 | 0.060 |
Why?
|
| Bacteremia | 1 | 2006 | 98 | 0.060 |
Why?
|
| Heparin | 1 | 2005 | 22 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 60 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2005 | 33 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 270 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2010 | 2934 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2005 | 74 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2005 | 55 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2007 | 196 | 0.050 |
Why?
|
| Stroke | 1 | 2007 | 241 | 0.050 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2003 | 2 | 0.050 |
Why?
|
| Critical Illness | 1 | 2005 | 97 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 3717 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 438 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2003 | 66 | 0.050 |
Why?
|
| Clinical Competence | 2 | 2020 | 189 | 0.050 |
Why?
|
| Hepatitis C, Chronic | 1 | 2001 | 42 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2001 | 66 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2005 | 1412 | 0.040 |
Why?
|
| Learning Curve | 1 | 2020 | 14 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2001 | 146 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 14 | 0.040 |
Why?
|
| Physicians | 1 | 2001 | 104 | 0.040 |
Why?
|
| Animals | 1 | 2006 | 3255 | 0.040 |
Why?
|
| Peptic Ulcer | 1 | 1998 | 4 | 0.040 |
Why?
|
| United States | 3 | 2012 | 1762 | 0.040 |
Why?
|
| Michigan | 1 | 1997 | 17 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 1997 | 14 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 1997 | 28 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 86 | 0.030 |
Why?
|
| Fermentation | 1 | 2017 | 13 | 0.030 |
Why?
|
| Constipation | 1 | 2017 | 16 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2017 | 26 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 41 | 0.030 |
Why?
|
| Feces | 1 | 2017 | 80 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 1997 | 120 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 373 | 0.030 |
Why?
|
| Diet | 1 | 2017 | 178 | 0.030 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2015 | 6 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2015 | 30 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 356 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 124 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 1997 | 255 | 0.030 |
Why?
|
| Communication | 1 | 2015 | 96 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2012 | 2976 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2012 | 20 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 350 | 0.020 |
Why?
|
| Inpatients | 1 | 2012 | 113 | 0.020 |
Why?
|
| Neuroimaging | 1 | 2012 | 100 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2011 | 44 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 591 | 0.020 |
Why?
|
| Angiography | 1 | 2009 | 25 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 82 | 0.020 |
Why?
|
| Shock, Septic | 1 | 2008 | 25 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 225 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 122 | 0.020 |
Why?
|
| Critical Care | 1 | 2008 | 97 | 0.020 |
Why?
|
| Adolescent | 1 | 2012 | 1874 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 243 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2007 | 51 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2006 | 8 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 137 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2008 | 203 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2006 | 217 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 795 | 0.010 |
Why?
|
| Prevalence | 1 | 2006 | 375 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 312 | 0.010 |
Why?
|
| Brain | 1 | 2012 | 1202 | 0.010 |
Why?
|
| Radiography | 1 | 2005 | 523 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 1647 | 0.010 |
Why?
|
| Child | 1 | 2006 | 1153 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2001 | 40 | 0.010 |
Why?
|
| Data Collection | 1 | 2001 | 80 | 0.010 |
Why?
|
| Quality of Life | 1 | 2001 | 559 | 0.010 |
Why?
|